Bruhn Suzanne Louise

CIK 00015177908 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001517790

Recent Transactions

50 trades

Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-05-19+4,000→ 32,750 total
Award
Travere Therapeutics, Inc.$TVTX
Stock option (right to buy)
2026-05-19+12,000→ 12,000 total
Disposition to Issuer
Vigil Neuroscience, Inc.
Stock Option Award (Right to Buy)
2025-08-05−6,235→ 0 total
Disposition to Issuer
Vigil Neuroscience, Inc.
Stock Option Award (Right to Buy)
2025-08-05−24,073→ 0 total
Disposition to Issuer
Vigil Neuroscience, Inc.
Stock Option Award (Right to Buy)
2025-08-05−24,310→ 0 total
Disposition to Issuer
Vigil Neuroscience, Inc.
Stock Option Award (Right to Buy)
2025-08-05−18,068→ 0 total
Disposition to Issuer
Vigil Neuroscience, Inc.
Stock Option Award (Right to Buy)
2025-08-05−13,928→ 0 total
Disposition to Issuer
Vigil Neuroscience, Inc.
Common Stock
2025-08-05−5,000→ 0 total
Disposition to Issuer
Vigil Neuroscience, Inc.
Stock Option Award (Right to Buy)
2025-08-05−33,875→ 0 total
Award
Definium Therapeutics, Inc.$DFTX
Stock Option (Right to Buy)
2025-06-12+75,187→ 75,187 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock (Right to Buy)
2025-06-05+30,000→ 30,000 total
Award
Vigil Neuroscience, Inc.
Common Stock
2025-05-22+5,000→ 5,000 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-05-15+6,500→ 28,750 total
Award
Travere Therapeutics, Inc.$TVTX
Stock option (right to buy)
2025-05-15+19,500→ 19,500 total
Award
Vigil Neuroscience, Inc.
Stock Option Award (Right to Buy)
2025-03-03+33,875→ 33,875 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Common Stock (Right to Buy)
2024-06-13+26,764→ 26,764 total
Award
Definium Therapeutics, Inc.$DFTX
Stock Option (Right to Buy)
2024-06-10+16,506→ 16,506 total
Award
Vigil Neuroscience, Inc.
Stock Option Award (Right to Buy)
2024-06-05+18,068→ 18,068 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2024-05-08+6,500→ 22,250 total
Award
Travere Therapeutics, Inc.$TVTX
Stock option (right to buy)
2024-05-08+19,500→ 19,500 total
Disposition to Issuer
Vigil Neuroscience, Inc.
Stock Option Award (Right to Buy)
2024-05-03$7.62/sh−6,235→ 0 total
Award
Vigil Neuroscience, Inc.
Stock Option Award (Right to Buy)
2024-05-03+13,928→ 13,928 total
Disposition to Issuer
Vigil Neuroscience, Inc.
Stock Option Award (Right to Buy)
2024-05-03−13,928→ 0 total
Disposition to Issuer
Vigil Neuroscience, Inc.
Stock Option Award (Right to Buy)
2024-05-03−24,310→ 0 total
Award
Vigil Neuroscience, Inc.
Stock Option Award (Right to Buy)
2024-05-03+24,310→ 24,310 total
Award
Vigil Neuroscience, Inc.
Stock Option Award (Right to Buy)
2024-05-03+6,235→ 6,235 total
Award
Vigil Neuroscience, Inc.
Stock Option Grant (Right to Buy)
2024-03-01+24,073→ 24,073 total
Award
Definium Therapeutics, Inc.$DFTX
Common Shares
2023-06-21+13,671→ 19,623 total
Award
Definium Therapeutics, Inc.$DFTX
Stock Option (Right to Buy)
2023-06-21+19,203→ 27,267 total
Award
Vigil Neuroscience, Inc.
Stock Option Grant (Right to Buy)
2023-06-07+13,928→ 13,928 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (Right to Buy)
2023-06-07+14,000→ 14,000 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2023-05-17+4,500→ 15,750 total
Award
Travere Therapeutics, Inc.$TVTX
Stock option (right to buy)
2023-05-17+13,500→ 13,500 total
Award
Vigil Neuroscience, Inc.
Stock Option Grant (Right to Buy)
2023-03-01$7.62/sh+6,235→ 6,235 total
Award
Definium Therapeutics, Inc.$DFTX
Common Shares
2022-08-11+89,286→ 89,286 total
Award
Definium Therapeutics, Inc.$DFTX
Stock Option (Right to Buy)
2022-08-11+120,968→ 120,968 total
Award
Definium Therapeutics, Inc.$DFTX
Director's Deferred Share Units
2022-08-11+503,773→ 503,773 total
Award
Vigil Neuroscience, Inc.
Stock Option Grant (Right to Buy)
2022-07-27+24,310→ 24,310 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (right to buy)
2022-06-16+15,000→ 15,000 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2022-05-11+3,000→ 11,250 total
Award
Travere Therapeutics, Inc.$TVTX
Stock option (right to buy)
2022-05-11+9,000→ 9,000 total
Award
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2021-09-30+5,204→ 5,204 total
Award
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2021-06-30+3,465→ 3,465 total
Award
PLIANT THERAPEUTICS, INC.$PLRX
Stock Option (right to buy)
2021-06-29+13,286→ 13,286 total
Award
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2021-06-15+40,000→ 40,000 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2021-05-14+3,000→ 8,250 total
Award
Travere Therapeutics, Inc.$TVTX
Stock option (right to buy)
2021-05-14+9,000→ 9,000 total
Award
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2021-03-31+4,173→ 4,173 total
Award
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2020-12-31+4,254→ 4,254 total
Award
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2020-09-30+4,325→ 4,325 total

Bruhn Suzanne Louise

Recent Transactions

Companies

Recent Filings

Address